相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2014)
Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies
R. Constantinescu et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
Karin D. van Dijk et al.
MOVEMENT DISORDERS (2013)
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti et al.
NATURE REVIEWS NEUROLOGY (2013)
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Brit Mollenhauer et al.
NEUROSCIENCE LETTERS (2013)
Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
Yaroslau Compta et al.
PARKINSONISM & RELATED DISORDERS (2013)
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
Malin Wennstrom et al.
PLOS ONE (2013)
Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
Devika P. Bagchi et al.
PLOS ONE (2013)
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease
Jere E. Meredith et al.
PLOS ONE (2013)
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang et al.
JAMA NEUROLOGY (2013)
Cerebrospinal fluid biomarker candidates for Parkinsonian disorders
Radu Constantinescu et al.
FRONTIERS IN NEUROLOGY (2013)
Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Fuyuki Tateno et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies
David S. Goldstein et al.
BRAIN (2012)
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia
Stefan Lehnert et al.
EXPERIMENTAL NEUROLOGY (2012)
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Connie Luk et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
Noriko Ishigami et al.
MOVEMENT DISORDERS (2012)
Applying bioinformatics to proteomics: Is machine learning the answer to biomarker discovery for PD and MSA?
Hayley A. Mattison et al.
MOVEMENT DISORDERS (2012)
Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?
H. Bea Kuiperij et al.
NEUROBIOLOGY OF AGING (2012)
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
P. G. Foulds et al.
NEUROBIOLOGY OF DISEASE (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
Sara Bech et al.
PARKINSONISM & RELATED DISORDERS (2012)
The DJ-1 concentration in cerebrospinal fluid does not differentiate among parkinsonian syndromes
Lisette Salvesen et al.
PARKINSONISM & RELATED DISORDERS (2012)
Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson's Disease Dementia
Sarah Jesse et al.
PLOS ONE (2012)
Phosphorylated α-Synuclein in Parkinson's Disease
Yu Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
α-Synuclein in Parkinson's Disease
Leonidas Stefanis
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
Yu Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease
Peter LeWitt et al.
BRAIN RESEARCH (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
Michael R. Sierks et al.
INTEGRATIVE BIOLOGY (2011)
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
M. Andersson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naive Patients with Parkinson's Disease
Min Jeong Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE (2011)
CSF α-synuclein, tau, and amyloid β in Parkinson's disease reply
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Pathological roles of α-synuclein in neurological disorders (vol 10, pg 1015, 2011)
K. Vekrellis et al.
LANCET NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
Corticobasal degeneration: a pathologically distinct 4R tauopathy
Naomi Kouri et al.
NATURE REVIEWS NEUROLOGY (2011)
Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
Annika Ohrfelt et al.
NEUROCHEMICAL RESEARCH (2011)
TAU FORMS IN CSF AS A RELIABLE BIOMARKER FOR PROGRESSIVE SUPRANUCLEAR PALSY
H. Bea Kuiperij et al.
NEUROLOGY (2011)
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Claire Henchcliffe et al.
PROGRESS IN NEUROBIOLOGY (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Pathological roles of α-synuclein in neurological disorders
Kostas Vekrellis et al.
LANCET NEUROLOGY (2011)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies
J. Vandrovcova et al.
CURRENT ALZHEIMER RESEARCH (2010)
Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease
W. Michael Caudle et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Biomarker promise for Parkinson's disease
[Anonymous]
LANCET NEUROLOGY (2010)
DJ-1, PINK1, and Their Effects on Mitochondrial Pathways
Mark R. Cookson
MOVEMENT DISORDERS (2010)
Differential Pattern of Brain-Specific CSF Proteins Tau and Amyloid-Beta in Parkinsonian Syndromes
Sigurd D. Suessmuth et al.
MOVEMENT DISORDERS (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
T. Tokuda et al.
NEUROLOGY (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2010)
Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2010)
CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
Moeko Noguchi-Shinohara et al.
BRAIN RESEARCH (2009)
The genetics of Parkinson's syndromes: a critical review
John Hardy et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
Yaroslau Compta et al.
MOVEMENT DISORDERS (2009)
Biological fluid biomarkers in neurodegenerative parkinsonism
Michael Eller et al.
NATURE REVIEWS NEUROLOGY (2009)
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
L. Parnetti et al.
NEUROBIOLOGY OF DISEASE (2009)
8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases
K. Gmitterova et al.
NEURODEGENERATIVE DISEASES (2009)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2008)
The progression of pathology in longitudinally followed patients with Parkinson's disease
Glenda Halliday et al.
ACTA NEUROPATHOLOGICA (2008)
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
Lucilla Parnetti et al.
BIOLOGICAL PSYCHIATRY (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
B. Borroni et al.
NEUROLOGY (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
Chiara Balducci et al.
MOVEMENT DISORDERS (2007)
Low plasma uric acid level in Parkinson's disease
Tua Annanmaki et al.
MOVEMENT DISORDERS (2007)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
C. Ballard et al.
NEUROLOGY (2006)
Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of parkinsonian syndromes
Johannes Brettschneider et al.
MOVEMENT DISORDERS (2006)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies
R de Silva et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
